DYADIC INTERNATIONAL INC Award Undrlyg Securities Amt
DYADIC INTERNATIONAL INC (DYAI) had Award Undrlyg Securities Amt of 25.00 thousand Segment as of 2025-12-31, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes
ecd:AwardUndrlygSecuritiesAmt · last filed 2026-05-12
- 2025-12-31: Award Undrlyg Securities Amt 25.00K Segment.
Segment
| Period end | Award Undrlyg Securities Amt |
|---|---|
| 2025-12-31 | 25.00K Segment 10-K/A · filed 2026-04-30 |
shares
| Period end | Award Undrlyg Securities Amt |
|---|---|
| 2025-05-30 | 25.00K shares DEF 14A · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |